Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhito Nannya

Showing results (1-10 of 335) with videos related to

Pageof 34
Sort By:
JMA Journal|May 9, 2024
Addressing Information Gaps and Revising Coverage Terms and Conditions for Cancer Panel TestingYasuhito Nannya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Novel therapies for higher-risk myelodysplastic syndromes]Yasuhito Nannya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Progress in the diagnosis of and therapy for MDSYasuhito Nannya
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Indication and outcomes of hematopoietic stem cell transplantation for MDS]Yasuhito Nannya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 2022
[NGS-based multi-gene panel testing in hematological malignancies: germline variants and related issues]Yasuhito Nannya
Journal of Bone and Mineral Metabolism|November 8, 2022
Factors associated with clonal hematopoiesis and interaction with marrow environmentYasuhito Nannya
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Acute myeloid leukemia]Yasuhito Nannya, Mineo Kurokawa
Leukemia Research|May 15, 2012
Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysisYuki Kagoya, Yasuhito Nannya, Mineo Kurokawa
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 2012
Evaluation of procalcitonin with liquid-phase binding assay in hematological malignancyJunji Koya, Yasuhito Nannya, Mineo Kurokawa
Leukemia & Lymphoma|July 4, 2014
Role of procalcitonin and C-reactive protein for discrimination between tumor fever and infection in patients with hematological diseasesSho Hangai, Yasuhito Nannya, Mineo Kurokawa
Pageof 34

Showing results (1-10 of 335) with videos related to

Sort By:
Pageof 34
JMA Journal|May 9, 2024
Addressing Information Gaps and Revising Coverage Terms and Conditions for Cancer Panel TestingYasuhito Nannya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Novel therapies for higher-risk myelodysplastic syndromes]Yasuhito Nannya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Progress in the diagnosis of and therapy for MDSYasuhito Nannya
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Indication and outcomes of hematopoietic stem cell transplantation for MDS]Yasuhito Nannya
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 2022
[NGS-based multi-gene panel testing in hematological malignancies: germline variants and related issues]Yasuhito Nannya
Journal of Bone and Mineral Metabolism|November 8, 2022
Factors associated with clonal hematopoiesis and interaction with marrow environmentYasuhito Nannya
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Acute myeloid leukemia]Yasuhito Nannya, Mineo Kurokawa
Leukemia Research|May 15, 2012
Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysisYuki Kagoya, Yasuhito Nannya, Mineo Kurokawa
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 2012
Evaluation of procalcitonin with liquid-phase binding assay in hematological malignancyJunji Koya, Yasuhito Nannya, Mineo Kurokawa
Leukemia & Lymphoma|July 4, 2014
Role of procalcitonin and C-reactive protein for discrimination between tumor fever and infection in patients with hematological diseasesSho Hangai, Yasuhito Nannya, Mineo Kurokawa
Pageof 34